Low-dose versus high-dose heparinization during arteriovenous carbon dioxide removal

Abstract

The purpose of this study was to compare low-dose (LD) and high-dose (HD) systemic heparinization in a prospective randomized study of arteriovenous carbon dioxide removal (AVCO₂R) during acute respiratory distress syndrome, using a commercially available heparin-coated oxygenator. Adult sheep (n = 13) received an LD₅₀ smoke inhalation and 40% TBSA third degree cutaneous flame burn injury. At 40-48 h post-injury, animals underwent cannulation of the carotid artery and jugular vein and were then randomized to HD heparin (activated clotting time, ACT > 300 s, n = 6) and LD heparin (ACT > 200 s, n = 7) and placed on AVCO₂R for approximately 72 h using an oxygenator with the Trillium Bio-Passive Surface™. Mean ACTs were significantly different, as expected (HD: 446 ± 26 s, LD: 213 ± 12 s, p < 0.05). AVCO₂R shunt flow averaged approximately 13% of cardiac output with mean CO₂ removal similar in HD and LD, p = NS. The hematocrit, platelet count, and fibrin degradation products for the two groups were not different. No differences in thrombosis or bleeding were noted. In conclusion, LD systemic heparin (ACT < 200 s) with a heparin-coated oxygenator does not increase thrombogenicity during AVCO₂R for smoke/burn-induced severe lung injury in sheep.

Get full access to this article

View all access options for this article.

References

Extracorporeal Life Support Organization (ELSO) Registry. Ann Arbor, MI , 1999.

Alpard SK , Zwischenberger JB. Extracorporeal gas exchange . Respir Care Clin N Am 1998; 4: 711-738 .

Zwischenberger JB , Nguyen TT , Upp Jr JR et al. Complications of neonatal extracorporeal membrane oxygenation. Collective experience from the Extracorporeal Life Support Organization . J Thorac Cardiovasc Surg 1994; 107: 838-849 .

Brunston Jr RL , Zwischenberger JB , Tao W , Cardenas Jr VJ , Traber DL , Bidani A. Total arteriovenous CO2 removal: simplifying extracorporeal support for respiratory failure . Ann Thorac Surg 1997; 64: 1599-1605 .

Brunston Jr RL , Tao W , Bidani A , Alpard SK , Traber DL , Zwischenberger JB. Prolonged hemodynamic stability during arteriovenous carbon dioxide removal for severe respiratory failure . J Thorac Cardiovasc Surg 1997; 114: 1107-1114 .

Zwischenberger JB , Alpard SK , Tao W , Deyo DJ , Bidani A. Percutaneous arteriovenous carbon dioxide removal improves survival in respiratory distress syndrome: a prospective randomized outcomes study in sheep . Surg Forum 1999; 50: 140-142 .

Zwischenberger JB , Conrad SA , Alpard SK , Grier LR , Bidani A. Percutaneous extracorporeal arteriovenous CO2 removal for severe respiratory failure . Ann Thorac Surg 1999; 68: 181-187 .

Edmunds LHJ , Stenach N. Surface interface. In: Gravlee GP , Davis RF , Kurusz M , Utley JR eds. Cardiopulmonary bypass principles and practice, 2nd edition. Baltimore, MD: Lippincott Williams & Wilkins , 2000: 149-166.

von Segesser LK. Heparin-bonded surfaces in extracorporeal membrane oxygenation for cardiac support . Ann Thorac Surg 1996; 61: 330-335 .

10.

Alpard SK , Zwischenberger JB , Tao W , Deyo DJ , Traber DL , Bidani A. New clinically relevant sheep model of severe respiratory failure secondary to combined smoke inhalation/cutaneous flame burn injury . Crit Care Med 2000; 28: 1469-1476 .

11.

Waymack JP , Rutan RL , Herndon DN. Burns. In: Sabiston Jr DJ , Lyrley HK , eds. Sabiston’s essentials of surgery, 2nd edition. Philadelphia, PA: WB Saunders , 1994: 91-97.

12.

Alpard SK , Zwischenberger JB , Tao W , Deyo DJ , Bidani A. Reduced ventilator pressure and improved P/F ratio during percutaneous arteriovenous carbon dioxide removal for severe respiratory failure . Ann Surg 1999; 230: 215-224 .

13.

Tillman P , Carson SN , Talken L. Platelet function and coagulation parameters in sheep during experimental vascular surgery . Lab Anim Sci 1981; 31: 263-267 .

14.

Wakabayashi A , Woolley TO , Nakamura Y et al. Blood coagulation studies during six day heparinless venoarterial bypass in sheep . J Surg Oncol 1976; 8: 299-304 .

15.

Greenwood B. Haematology of the sheep and goat: (a) the sheep. In: Archer RK , Jeffcott LB , Lehmann H eds. Comparative clinical haematology. Oxford: Blackwells , 1977: 305-355.

16.

Lesserson S , Gravlee GP. Anticoagulation for cardiopulmonary bypass. In: Gravlee GP , Davis RF , Kurusz M , Utley JR eds. Cardiopulmonary bypass principles and practice. Baltimore, MD: Lippincott Williams & Wilkins , 1993: 340-380.

17.

Graves DF , Chernin JM , Kurusz M , Zwischenberger JB. Anticoagulation practices during neonatal extracorporeal membrane oxygenation: survey results . Perfusion 1996; 11: 461-466 .

18.

Hsu L-C. Principles of heparin-coating techniques . Perfusion 1991; 6: 209-219 .

19.

Larm O , Larsson R , Olsson P. A new nonthrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue . Biomater Med Devices Artif Organs 1983; 11: 161-173 .

20.

Ovrum E , Mollnes TE , Fosse E et al. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits . J Thorac Cardiovasc Surg 1995; 110: 1623-1632 .

21.

Moen O , Fosse E , Brockmeier V et al. Disparity in blood activation by two different heparin-coated cardiopulmonary bypass systems . Ann Thorac Surg 1995; 60: 1317-1323 .

22.

Baba T , Morisita K , Sakata J et al. Experimental studies on three types of heparin-coated cardiopulmonary bypass circuits . Artif Organs 1997; 21: 779-781 .

23.

Wendel HP , Ziemer G. Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation . Eur J Cardiothorac Surg 1999; 16: 342-350 .

24.

Ashraf S , Tian Y , Cowan D , Entress A , Martin PG , Watterson KG. Release of proinflammatory cytokines during pediatric cardiopulmonary bypass: heparin-bonded versus nonbonded oxygenators . Ann Thorac Surg 1997; 64: 1790-1794 .

25.

Mahoney CB. Heparin-bonded circuits: clinical outcomes and costs . Perfusion 1998; 13: 192-204 .

26.

Ranucci M , Mazzucco A , Pessotto R et al. Heparin-coated circuits for high-risk patients: a multicenter, prospective, randomized trial . Ann Thorac Surg 1999; 67: 994-1000 .

27.

Kuitunen AH , Heikkila LJ , Salmenpera MT. Cardiopulmonary bypass with heparin-coated circuits and reduced systemic anticoagulation . Ann Thorac Surg 1997; 63: 438-444 .